Skip to main content

Advertisement

SpringerLink
Log in

Management of Odontogenic Fascial Space Infection in Hemophilia Patients: A Proposed Protocol

  • Clinical Paper
  • Published:
Journal of Maxillofacial and Oral Surgery Aims and scope Submit manuscript

Abstract

Purpose

The purpose of this study was to suggest a protocol for the management of odontogenic space infections in patients with hemophilia which is often incompletely addressed by clinicians because of the fear of excessive bleeding leading to prolonged morbidity.

Methods and Results

Six diagnosed cases of hemophilia (four cases of hemophilia A and two cases of hemophilia B) with odontogenic fascial space infection were included in the study. Apart from routine investigations, assessments were also done to identify inhibitors to factor VIII/IX. Factor VIII/IX was replaced along with infusion of factor eight inhibitor bypass activity (FEIBA) one hour before incision and drainage. All the cases were treated by incision and drainage along with removal of foci under local anesthesia. The postoperative outcome was uneventful in all cases except one in which postoperative bleeding was noted from the extraction site on the third day which was again managed following the designed protocol.

Conclusion

Maintaining good oral hygiene and seeking early dental care are of prime importance in patients with hemophilia to avoid invasive procedures. However, if odontogenic infection develops in these patients, performing timely incision and drainage using our protocol will minimize the complications and give successful outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Patton LL (2003) Bleeding and clotting disorders. In: Burket’s oral medicine: diagnosis and treatment. 10th edn. BC Decker, Hamilton, pp 454–477

  2. Rickard K (1995) Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia 1(Suppl.l):8–13

    Article  PubMed  Google Scholar 

  3. Stubbs M, Lloyd J (2001) A protocol for the dental management of von Willebrand’s disease, haemophilia A and haemophilia B. Aust Dent J 46(1):37–40

    Article  CAS  PubMed  Google Scholar 

  4. Lloyd J et al (2000) Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders in Australia. Melbourne, Medical Advisory Panel for HFA (AHCDO)

    Google Scholar 

  5. Sudheesh KM et al (2016) ‘Antihemophilic factor is not the only answer for all factor VIII deficiencies’. Case report of odontogenic infection in a patient with hemophilia A, complicated by factor VIII inhibitors, and managed by transfusion of antihemophilic factor and factor VIII inhibitor bypass activity. Indian J Dent 7(3):149–152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Franchini M (2014) Current management of hemophilia B: recommendations, complications and emerging issues. Expert Rev Hematol 7(5):573–581

    Article  CAS  PubMed  Google Scholar 

  7. Bahl R, Sandhu S, Singh K, Sahai N, Gupta M (2014) Odontogenic infections: microbiology and management. Contemp Clin Dent 5(3):307–311

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rafique S, Fiske J, Palmer G, Daly B (2013) Special care dentistry, 1: dental management of patients with inherited bleeding disorders. Dent Update 40(8):613–616

    Article  PubMed  Google Scholar 

  9. Farrkh A, Garrison E, Closmann JJ (2016) Dental surgical management of the patient with hemophilia. Gen Dent 64(4):14–17

    PubMed  Google Scholar 

  10. Nilsson IM (1994) Hemophilia. Pharmacia Plasma Products, Stockholm

    Google Scholar 

  11. Shapiro SS, Huntin M (1975) Acquired inhibitors to the blood coagulation factors. Sem Thromb Hemost 1:336

    Google Scholar 

  12. Sultan Y (1992) The French Hemophilia Study Group. Prevalence of inhibitors in a population of 3435 hemophilia patients in France. Thromb Haemost 67:600–602

    Article  CAS  PubMed  Google Scholar 

  13. Kasper CK (1989) Treatment of factor VIII inhibitors. Prog Hemost Thromb 9:57–86

    CAS  PubMed  Google Scholar 

  14. Lusher JM (1987) Factor VIII inhibitors. Etiology, characterization, natural history, and management. Ann N Y Acad Sci 509:89–102

    Article  CAS  PubMed  Google Scholar 

  15. Nilsson IM, Hedner U, Björlin G (1973) Suppression of factor IX antibody in hemophilia B by factor IX and cyclophosphamide. Ann Intern Med 78:91–95

    Article  CAS  PubMed  Google Scholar 

  16. Nilsson IM, Hedner U (1976) Immunosuppressive treatment in haemophiliacs with inhibitors to factor VIII and factor IX. Scand J Haematol 16:369–382

    Article  CAS  PubMed  Google Scholar 

  17. Brewer A (2008) Dental management of patients with inhibitors to factor VIII or factor IX. World Federation of Haemophilia, Montréal (treatment of haemophilia monograph, no 45)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, Aligarh Muslim University, Aligarh, Uttar Pradesh, 202002, India

    Md. Kalim Ansari, Ghulam sarwar Hashmi, Syed Saeed Ahmed, Sajjad Abdur Rahman & Tabishur Rahman

Authors
  1. Md. Kalim Ansari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ghulam sarwar Hashmi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Syed Saeed Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sajjad Abdur Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tabishur Rahman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Md. Kalim Ansari.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Informed Consent

Informed consents were obtained from all the patients.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ansari, M.K., Hashmi, G.s., Ahmed, S.S. et al. Management of Odontogenic Fascial Space Infection in Hemophilia Patients: A Proposed Protocol. J. Maxillofac. Oral Surg. 18, 197–202 (2019). https://doi.org/10.1007/s12663-018-1117-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12663-018-1117-0

Keywords

Search

Navigation